Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Print
ISSN
1434-6621
See all formats and pricing
More options …
Volume 57, Issue 6

Issues

Evaluation of immature platelet fraction in patients with myelodysplastic syndromes. Association with poor prognosis factors

Alex Larruzea Ibarra
  • Corresponding author
  • Specialist in Clinical Chemistry, Clinical Laboratory, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain, Phone: +34678831873
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Luz Muñoz Marín
  • Clinical Laboratory, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Granada Perea Durán
  • Clinical Laboratory, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Montserrat Torra Puig
  • Clinical Laboratory, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-10-23 | DOI: https://doi.org/10.1515/cclm-2018-0784

References

  • 1.

    Hoffmann JJ. Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med 2014;52:1107–17.PubMedWeb of ScienceGoogle Scholar

  • 2.

    Pons I, Monteagudo M, Lucchetti G, Muñoz L, Perea G, Colomina I, et al. Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia. Eur J Haematol 2010;85:158–63.PubMedWeb of ScienceGoogle Scholar

  • 3.

    Sugimori N, Kondo Y, Shibayama M, Omote M, Takami A, Sugimori C, et al. Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis. Eur J Haematol 2009;82:54–60.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 4.

    Saigo K, Takenokuchi M, Imai J, Numata K, Isono S, Zenibayashi M, et al. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes. Lab Hematol 2009;15:13–6.PubMedCrossrefGoogle Scholar

  • 5.

    Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012;120:2454–65.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 6.

    Piva E, Brugnara C, Spolaore F, Plebani M. Clinical utility of reticulocyte parameters. Clin Lab Med 2015;35:133–63.CrossrefWeb of SciencePubMedGoogle Scholar

  • 7.

    Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93–9.CrossrefPubMedGoogle Scholar

  • 8.

    Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006;118:463–9.CrossrefPubMedGoogle Scholar

About the article

Received: 2018-07-24

Accepted: 2018-09-30

Published Online: 2018-10-23

Published in Print: 2019-05-27


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 6, Pages e128–e130, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-0784.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in